|
Secretin Clinical Trials
1 actively recruiting trial across 1 location
Also known as: ChiRhoStim
Pipeline
Phase 3: 1
Top Sponsors
- Johns Hopkins University1
Indications
- Germline Mutation Carrier1
- Gene Mutation1
- Peutz-Jeghers Syndrome (PJS)1
- Lynch Syndrome1
- Pancreas Cancer1
New Haven, Connecticut1 trial
The Cancer of the Pancreas Screening-5 CAPS5)Study
Yale University
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.